Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
Saved in:
| Published in | Clinical pharmacology and therapeutics Vol. 84; no. 6; p. 679 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
01.12.2008
|
| Subjects | |
| Online Access | Get more information |
Cover
Loading…
| Author | Van Hoydonck, P De Smet, M Gendrano, 3rd, I N Bloomfield, D M Bergman, A J Cote, J Van Dyck, K Gottesdiener, K M Wagner, J A Laethem, T Krishna, R Laterza, O Al-Huniti, N Snyder, K Gutierrez, M Chen, J Chavez-Eng, C Lutz, R Dykstra, K Fallon, M Hilliard, D Van Bortel, L M Jin, B |
|---|---|
| Author_xml | – sequence: 1 givenname: R surname: Krishna fullname: Krishna, R email: rajesh_krishna@merck.com organization: Merck & Co., Inc., Whitehouse Station, New Jersey, USA. rajesh_krishna@merck.com – sequence: 2 givenname: A J surname: Bergman fullname: Bergman, A J – sequence: 3 givenname: B surname: Jin fullname: Jin, B – sequence: 4 givenname: M surname: Fallon fullname: Fallon, M – sequence: 5 givenname: J surname: Cote fullname: Cote, J – sequence: 6 givenname: P surname: Van Hoydonck fullname: Van Hoydonck, P – sequence: 7 givenname: T surname: Laethem fullname: Laethem, T – sequence: 8 givenname: I N surname: Gendrano, 3rd fullname: Gendrano, 3rd, I N – sequence: 9 givenname: K surname: Van Dyck fullname: Van Dyck, K – sequence: 10 givenname: D surname: Hilliard fullname: Hilliard, D – sequence: 11 givenname: O surname: Laterza fullname: Laterza, O – sequence: 12 givenname: K surname: Snyder fullname: Snyder, K – sequence: 13 givenname: C surname: Chavez-Eng fullname: Chavez-Eng, C – sequence: 14 givenname: R surname: Lutz fullname: Lutz, R – sequence: 15 givenname: J surname: Chen fullname: Chen, J – sequence: 16 givenname: D M surname: Bloomfield fullname: Bloomfield, D M – sequence: 17 givenname: M surname: De Smet fullname: De Smet, M – sequence: 18 givenname: L M surname: Van Bortel fullname: Van Bortel, L M – sequence: 19 givenname: M surname: Gutierrez fullname: Gutierrez, M – sequence: 20 givenname: N surname: Al-Huniti fullname: Al-Huniti, N – sequence: 21 givenname: K surname: Dykstra fullname: Dykstra, K – sequence: 22 givenname: K M surname: Gottesdiener fullname: Gottesdiener, K M – sequence: 23 givenname: J A surname: Wagner fullname: Wagner, J A |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18580870$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kDtPwzAUhS0EoqUwsiKPIDXFjuPGHlFVHlIRDGWuHPtGcUkcK3aH_BD-L-a5nHPup6Mz3DN07HoHCF1SsqCEiVvd-rjICRHplEdoSjnLsyVnfILOQtgTQgopxCmaUMEFESWZoo_nQxutbyEzfQDsGzV0SvdmdKqzOmDlzD98tw7iF-zrxJWGOChvqzlW2PcRXMS66VsIEYaxxd-OU8WFOgU_pIp1-Hq13r7eYOsaW9nYD_MUcQOqjc2Iw6Hag47hHJ3Uqg1w8esz9Ha_3q4es83Lw9PqbpNpVlKZMSO4MbzkhBYlB8ZAlTIJlIoZLXNV1aBBCFPoohRSUEUkB1lXsqBLnpN8hq5-dv2h6sDs_GA7NYy7v__kn5nyaxI |
| CitedBy_id | crossref_primary_10_1016_j_pharmthera_2012_03_004 crossref_primary_10_1002_cpt_700 crossref_primary_10_1007_s11883_023_01184_1 crossref_primary_10_3109_00498254_2013_874611 crossref_primary_10_2165_11599310_000000000_00000 crossref_primary_10_1161_ATVBAHA_115_306680 crossref_primary_10_3390_pharmaceutics11070336 crossref_primary_10_1002_ddr_20282 crossref_primary_10_1002_jcph_320 crossref_primary_10_1016_j_clinthera_2011_05_046 crossref_primary_10_1517_14656566_2016_1129402 crossref_primary_10_1161_ATVBAHA_116_308262 crossref_primary_10_1517_13543784_2011_614946 crossref_primary_10_1194_jlr_M008706 crossref_primary_10_1021_jm200484c crossref_primary_10_1161_CIRCOUTCOMES_116_003121 crossref_primary_10_1016_j_bmcl_2010_11_090 crossref_primary_10_1194_jlr_M057794 crossref_primary_10_1111_j_1365_2125_2009_03385_x crossref_primary_10_1124_dmd_109_028696 crossref_primary_10_1177_1074248415575153 crossref_primary_10_1016_j_amjcard_2009_09_017 crossref_primary_10_1007_s12325_021_01794_8 crossref_primary_10_1345_aph_1P446 crossref_primary_10_1002_jcph_97 crossref_primary_10_1007_s40262_013_0071_8 crossref_primary_10_3390_pharmaceutics12060573 crossref_primary_10_1002_bdd_776 crossref_primary_10_1016_j_bmcl_2009_10_099 crossref_primary_10_1093_eurheartj_ehr348 crossref_primary_10_1111_j_1755_5922_2010_00142_x crossref_primary_10_1194_jlr_M036509 crossref_primary_10_1002_prp2_70010 crossref_primary_10_1016_j_amjcard_2013_08_041 crossref_primary_10_1021_acs_jmedchem_1c00959 crossref_primary_10_1016_j_ahj_2011_07_010 crossref_primary_10_1016_j_ahj_2011_11_017 crossref_primary_10_1038_clpt_2009_120 crossref_primary_10_1208_s12248_011_9254_0 crossref_primary_10_1080_00325481_2018_1401421 crossref_primary_10_1097_CRD_0000000000000245 crossref_primary_10_2217_fca_12_25 crossref_primary_10_1080_17425255_2017_1262347 crossref_primary_10_1097_HCO_0b013e32832ac166 crossref_primary_10_1002_bmc_3791 crossref_primary_10_2217_bmm_10_107 crossref_primary_10_1111_bcp_12380 crossref_primary_10_1007_s11883_011_0217_9 crossref_primary_10_1194_jlr_M041541 crossref_primary_10_1111_j_1365_2125_2012_04171_x crossref_primary_10_1016_j_atherosclerosis_2013_05_012 crossref_primary_10_1016_j_jacl_2014_10_005 crossref_primary_10_1111_j_1365_2125_2009_03465_x crossref_primary_10_1586_erc_10_4 crossref_primary_10_1016_j_atherosclerosis_2014_05_931 crossref_primary_10_1002_jlcr_3073 crossref_primary_10_1038_psp_2013_70 crossref_primary_10_1016_j_phrs_2017_12_028 crossref_primary_10_1007_s12170_011_0206_0 crossref_primary_10_1177_0091270010368676 crossref_primary_10_1016_j_jchromb_2015_12_053 crossref_primary_10_1097_MOL_0b013e3283475e00 crossref_primary_10_1002_jcph_1004 crossref_primary_10_1517_13543784_2012_642499 crossref_primary_10_1517_14728214_2011_554395 crossref_primary_10_1111_jphp_12287 crossref_primary_10_1124_dmd_109_028704 crossref_primary_10_1021_jm400574e crossref_primary_10_1016_j_bmcl_2011_11_039 crossref_primary_10_1002_jcph_1287 crossref_primary_10_4155_bio_09_42 crossref_primary_10_1038_s41591_022_01936_7 crossref_primary_10_1093_eurheartj_ehu319 crossref_primary_10_1194_jlr_M007468 crossref_primary_10_1097_CRD_0000000000000023 crossref_primary_10_1124_dmd_115_067736 crossref_primary_10_1016_j_pharmthera_2013_04_012 crossref_primary_10_1007_s11906_009_0014_9 crossref_primary_10_1016_j_atherosclerosis_2016_03_017 crossref_primary_10_1021_jm500431d crossref_primary_10_1038_clpt_2011_271 crossref_primary_10_1007_BF03191385 crossref_primary_10_1194_jlr_M016410 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM |
| DOI | 10.1038/clpt.2008.109 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1532-6535 |
| ExternalDocumentID | 18580870 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K -Q- .55 .GJ 0R~ 1B1 1CY 1OB 1OC 29B 33P 354 36B 39C 3O- 4.4 52O 53G 5GY 5RE 6J9 70F 8F7 AAESR AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AAQOH AAQQT AAWTL AAYCA AAZKR ABCUV ABJNI ABLJU ABQWH ACBNA ACBWZ ACCZN ACGFO ACGFS ACGOF ACPOU ACRPL ACXQS ACYXJ ADBBV ADBTR ADKYN ADNMO ADXAS ADZCM ADZMN AEFGJ AEGXH AEIGN AENEX AEUYR AEYWJ AFBPY AFFNX AFFPM AGHNM AGQPQ AGXDD AGYGG AHBTC AI. AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BMXJE BRXPI C45 CAG CGR COF CS3 CUY CVF DCZOG DPXWK DU5 EBS ECM EE. EIF EJD EMOBN F5P GODZA GWYGA HGLYW IH2 IHE J5H L7B LATKE LEEKS LITHE LOXES LSO LUTES LYRES M41 MEWTI N4W N9A NPM NQ- O9- OPC OVD P2P P2W PALCI RIG RIWAO RJQFR RNTTT ROL RPZ SAMSI SEW SJN SUPJJ TEORI TWZ UHS VH1 WBKPD WH7 WOHZO WXSBR X7M Y6R YFH YOC YXB ZGI ZXP ZZTAW |
| ID | FETCH-LOGICAL-c3719-3d85dd57501475e33ea793eae7a3dc92abfece88d4c478981a095e9fb94165202 |
| IngestDate | Mon Jul 21 06:04:36 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c3719-3d85dd57501475e33ea793eae7a3dc92abfece88d4c478981a095e9fb94165202 |
| PMID | 18580870 |
| ParticipantIDs | pubmed_primary_18580870 |
| PublicationCentury | 2000 |
| PublicationDate | December 2008 |
| PublicationDateYYYYMMDD | 2008-12-01 |
| PublicationDate_xml | – month: 12 year: 2008 text: December 2008 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Clinical pharmacology and therapeutics |
| PublicationTitleAlternate | Clin Pharmacol Ther |
| PublicationYear | 2008 |
| SSID | ssj0004988 |
| Score | 2.254515 |
| SourceID | pubmed |
| SourceType | Index Database |
| StartPage | 679 |
| SubjectTerms | Administration, Oral Adolescent Adult Cholesterol Ester Transfer Proteins - administration & dosage Cholesterol Ester Transfer Proteins - antagonists & inhibitors Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Humans Male Middle Aged Oxazolidinones - administration & dosage Oxazolidinones - pharmacokinetics Oxazolidinones - pharmacology Reference Values Risk Factors Sensitivity and Specificity Young Adult |
| Title | Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/18580870 |
| Volume | 84 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6lcOGCeL_RHFAFShaS9Wt9rKqiqlJQDqnUW7XeB1gUx2rdQ_gf_Bl-HbOv2AkPARd7tZtEVr5P65nZmW8IecVyJtFP0LQQpaCpMYwKnSiqp0WJBoXKc27rnecf8uPT9OQsOxuNvg-ylq676q38-su6kv9BFecQV1sl-w_Ibn4UJ3CM-OIVEcbrX2E8D9mAVNms8zaoUCvfZN6LL8fJz2hNOkVme-7fCKm7S9HW7jBGjNtVZ1MC7E7ohBPWF2N3tw0k0KzFgZNzqBt35nu0XNhYQt18qqu68-4-LvmKyvX46rqysZ2rodl7GOsv214pex2TN2P9V3-sZLve-1q1Pp1RX34MwdqD_ijrJHSb37Bwk0Yw3wpn8EFqiI5bMKN55kVM4h7t28gFLg433Ny3ovnpReBl3-VFG_JlZ9OtzyGO7RfHCrRX-JT75iV_Xt3R5Y5Le2QPPRTbctXGiWJFbsl5UHTFJ3m39RxWpzZ8d8eXcTbN8g65HZwROPDMuktGurlH9hceo_UElgNwJrAPiwF698m3LfrBLv0A4YVd-sHKwIB-ExDgyQcD8oG7QyQfBPLBa0u9N7Ah3gSHEGgHkXYPyOn7o-XhMQ1dPqhMillJE8UzpdBrQGe9yHSSaIHvDC10IRIlSyYqo6XmXKUyLXjJZwK9Al2aqkRfImNT9pDcaFaNfkwgVZVICyNZWiRo5leiZJXhiTAmK5jW_Al55P_u89ZLuZxHIJ7-duUZudXT9Dm5aXDv0C_QEO2qlw7zH9RIkHA |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiple-dose+pharmacodynamics+and+pharmacokinetics+of+anacetrapib%2C+a+potent+cholesteryl+ester+transfer+protein+%28CETP%29+inhibitor%2C+in+healthy+subjects&rft.jtitle=Clinical+pharmacology+and+therapeutics&rft.au=Krishna%2C+R&rft.au=Bergman%2C+A+J&rft.au=Jin%2C+B&rft.au=Fallon%2C+M&rft.date=2008-12-01&rft.eissn=1532-6535&rft.volume=84&rft.issue=6&rft.spage=679&rft_id=info:doi/10.1038%2Fclpt.2008.109&rft_id=info%3Apmid%2F18580870&rft_id=info%3Apmid%2F18580870&rft.externalDocID=18580870 |